LABORATORY CORP OF AMERICA HOLDINGS is 4.5x more valuable than Caris Life Sciences, Inc. by market capitalization ($22.03 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LH | CAI |
|---|---|---|
| Market cap | $22.03 B | $4.85 B |
| US-listed rank | #581 | #1404 |
| Revenue (latest FY) | $13.95B | $812.03M |
| Net income (latest FY) | $877.00M | -$68.09M |
| Net margin | 6.3% | -8.4% |
| P/E (trailing FY) | 25.1 | - |
| SEC filings | 3,857 | 102 |
LABORATORY CORP OF AMERICA HOLDINGS is 4.5x more valuable than Caris Life Sciences, Inc. by market capitalization ($22.03 B vs $4.85 B).
In their latest fiscal years, LABORATORY CORP OF AMERICA HOLDINGS reported $13.95B in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: LABORATORY CORP OF AMERICA HOLDINGS and Caris Life Sciences, Inc., or browse the full rankings.